Trendlines Group

SINGAPORE (May 23): CIMB Research has issued an unrated report on Trendlines Group as an “intensely hands-on technology” incubator based in Israel, and as a stock that is currently trading at a discount to its global peers.

SINGAPORE (April 11): Trendlines Group, the incubator for medical and agri-tech companies, aims to increase its number of portfolio companies, build value in these companies, expand into new markets as well as grow Trendlines Labs.

SINGAPORE (March 29): The Trendlines Group’s business unit Trendlines Labs, In partnership with the Singapore General Hospital (SGH), will receive a grant of up to US$0.2 million ($0.3 million) for the development and clinical trial for its Stress Urin

SINGAPORE (Feb 1): Trendlines Medical Singapore, the medical incubator subsidiary of Israeli firm Trendlines Group, will hold its official opening ceremony on Feb 22 at its office located at Launchpad @One North.

SINGAPORE (Jan 16): Trendlines Medical Singapore, the medical incubator subsidiary of Israeli firm Trendlines Group, will receive a grant of up to $2.2 million under SPRING Singapore’s Incubator Development Program.

SINGAPORE (Dec 21): Here are some factors and stocks that could move the market this Wednesday morning:

SINGAPORE (Dec 7): Here are some factors and stocks that could move the market this Wednesday morning:

SINGAPORE (Nov 9): Trendlines Group, the Israeli company focused on developing technology-based companies in the medical and agricultural fields, has swung back into the black in 3Q.

SINGAPORE (June 22): Trendlines Group says 26.46% associated company ET View Medical will be sold to Denmark-based Ambu A/S and privatised.

SINGAPORE (June 21): Trendlines Group announced that the Office of the Chief Scientist of the Israel Ministry of Economy (OCS) has approved Trendlines Medical’s request to establish 9 to 11 new portfolio companies a year in medical device and agtech fie